Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Obua BN"'
Autor:
Besci O; Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI 48109, USA.; Division of Pediatric Endocrinology, Dokuz Eylul University, Izmir 35340, Turkey., Foss de Freitas MC; Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI 48109, USA., Guidorizzi NR; Division of Internal Medicine, University of São Paulo, Ribeirão Preto, São Paulo 05508, Brazil., Guler MC; Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI 48109, USA.; Division of Internal Medicine, Dokuz Eylul University, Izmir 35340, Turkey., Gilio D; Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Clinical and Translational Sciences, University of Pisa, Pisa 56126, Italy., Maung JN; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48105, USA., Schill RL; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48105, USA., Hoose KS; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48105, USA., Obua BN; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48105, USA., Gomes AD; Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI 48109, USA., Yıldırım Şimşir I; Division of Endocrinology and Metabolism, Department of Internal Medicine, Ege University, Izmir 35100, Turkey., Demir K; Division of Pediatric Endocrinology, Dokuz Eylul University, Izmir 35340, Turkey., Akinci B; DEPARK, Dokuz Eylul University & Izmir Biomedicine and Genome Center, Izmir, Turkey.; Izmir Biomedicine and Genome Center, Izmir 35340, Turkey., MacDougald OA; Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI 48105, USA., Oral EA; Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI 48109, USA.
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Feb 20; Vol. 109 (3), pp. e1204-e1224.
Autor:
Kitajima S; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA; Department of Cell Biology, Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, Japan. Electronic address: shunsuke.kitajima@jfcr.or.jp., Tani T; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA., Springer BF; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, MA, USA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Campisi M; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA., Osaki T; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Institute of Industrial Science, The University of Tokyo, Tokyo, Japan., Haratani K; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA., Chen M; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA; Department of Immunology, Harvard Medical School, Boston, MA, USA., Knelson EH; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA; Pathology, Brigham and Women's Hospital, Boston, MA, USA., Ritter J; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA., Yoshida R; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA., Köhler J; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA., Ogino A; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA., Nozawa RS; Department of Experimental Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Sundararaman SK; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA; Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Thai TC; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA., Homme M; Department of Cell Biology, Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, Japan., Piel B; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA., Kivlehan S; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Obua BN; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Purcell C; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA; Division of Biology and Medicine, Brown University, Providence, RI, USA., Yajima M; Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, USA., Barbie TU; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Lizotte PH; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA., Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Gokhale PC; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, MA, USA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA LC4115, USA. Electronic address: david_barbie@dfci.harvard.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2022 Oct 10; Vol. 40 (10), pp. 1128-1144.e8. Date of Electronic Publication: 2022 Sep 22.